These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9703307)

  • 21. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metastatic breast carcinoma with neuroendocrine differentiation--its combined therapy with tamoxifen and the somatostatin analog octreotide].
    Rischke HC; Staib-Sebler E; Mose S; Adams SW; Herrmann G; Böttcher HD; Lorenz M
    Dtsch Med Wochenschr; 1999 Feb; 124(7):182-6. PubMed ID: 10093577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvant treatment for breast cancer in the elderly.
    Marchei P; Bianco V; Pignatelli E; Chiodini S; Santini D; Carico E; Marchei M; Vecchione A
    Anticancer Res; 1996; 16(2):911-3. PubMed ID: 8687150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
    Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
    Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cirrhosis-like radiological pattern in patients with breast cancer.
    Gómez Raposo C; Redondo Sánchez A; Guerra-Gutiérrez F; Castelo Fernández B; Gómez Senent S; Espinosa Arranz E; Martínez Martínez B; Zamora Auñón P; González Barón M
    Clin Transl Oncol; 2008 Feb; 10(2):111-6. PubMed ID: 18258510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Breast carcinoma--adjuvant chemo- and hormone therapy].
    Fey MF
    Ther Umsch; 1998 Jul; 55(7):413-4. PubMed ID: 9702106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.
    Dowsett M; Pfister C; Johnston SR; Miles DW; Houston SJ; Verbeek JA; Gundacker H; Sioufi A; Smith IE
    Clin Cancer Res; 1999 Sep; 5(9):2338-43. PubMed ID: 10499602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.
    Ingle JN; Suman VJ; Johnson PA; Krook JE; Mailliard JA; Wheeler RH; Loprinzi CL; Perez EA; Jordan VC; Dowsett M
    Clin Cancer Res; 1999 Jul; 5(7):1642-9. PubMed ID: 10430063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial cancer and tamoxifen.
    Burke C
    Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
    [No Abstract]   [Full Text] [Related]  

  • 31. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen-induced uterine abnormalities: the role of imaging.
    Ascher SM; Imaoka I; Lage JM
    Radiology; 2000 Jan; 214(1):29-38. PubMed ID: 10644098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI; Shepherd LE; Chapman JA; Norris BD; Cantin J; Goss PE; Dent SF; Walde D; Vandenberg TA; Findlay B; O'Reilly SE; Wilson CF; Han L; Piura E; Whelan TJ; Pollak MN
    J Clin Oncol; 2011 Oct; 29(29):3869-76. PubMed ID: 21911723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical hepatic toxicity during combination chemotherapy for breast cancer.
    Larroquette CA; Hortobagyi GN; Buzdar AU; Holmes FA
    JAMA; 1986 Dec; 256(21):2988-90. PubMed ID: 3773217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen for breast cancer.
    Karn A; Jha AK; Shrestha S; Acharya B; Poudel S; Bhandari RB
    JNMA J Nepal Med Assoc; 2010; 49(177):62-7. PubMed ID: 21180225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
    Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
    Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.
    Chourmouzi D; Boulogianni G; Zarampoukas T; Drevelengas A
    AJR Am J Roentgenol; 2003 Dec; 181(6):1673-5. PubMed ID: 14627594
    [No Abstract]   [Full Text] [Related]  

  • 39. Ocular toxicity of tamoxifen.
    Sekhar GC; Nagarajan R
    Indian J Ophthalmol; 1995 Mar; 43(1):23-6. PubMed ID: 8522365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography.
    Lindner J; Hillmann K; Blume-Peytavi U; Lademann J; Lux A; Stroux A; Schneider A; Garcia Bartels N
    Br J Dermatol; 2012 Dec; 167(6):1272-8. PubMed ID: 22834773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.